US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Brain Tumor - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
... therapeutic development for Brain Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Anaplastic Astrocytoma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
... therapeutic development for Anaplastic Astrocytoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Neurotech Industry 2014 Report
7/1/2014 | published by: NeuroInsights, LLC
... its 10th year, The Neurotechnology Industry 2014 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and ...  |  read more...
USD 5,500
Psychiatry Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... report provides a detailed understanding and analysis of how and why companies enter psychiatry partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right ...  |  read more...
USD 2,995
Major Depressive Disorder - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Major Depressive Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Brain Metastasis - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Brain Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Psychosis - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Psychosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Substance (Drug) Abuse - Pipeline Review, H2 2014
7/22/2014 | published by: Global Markets Direct
... information on the therapeutic development for Substance (Drug) Abuse, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014
7/28/2014 | published by: GlobalData
... information and data relating to the clinical trials on Obsessive-Compulsive Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Psychosis Global Clinical Trials Review, H2, 2014
7/28/2014 | published by: GlobalData
... relating to the clinical trials on Psychosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Schizoaffective Disorder Global Clinical Trials Review, H2, 2014
7/28/2014 | published by: GlobalData
... information and data relating to the clinical trials on Schizoaffective Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2014
7/28/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Seasonal Affective Disorder (SAD). It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Seizures Global Clinical Trials Review, H2, 2014
7/28/2014 | published by: GlobalData
... relating to the clinical trials on Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Biomarkers in Amyotrophic Lateral Sclerosis
8/1/2014 | published by: CHI Insight Pharma Reports
... a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the ALS space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With ...  |  read more...
USD 699
Tourette Syndrome - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Tourette Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Radical Innovations Based on Brain Computer Interface(BCI) (Technical Insights)
6/30/2014 | published by: Frost & Sullivan
... signals various parameters such as concentration levels, focus, and thoughts can be deciphered. These signals can then be used as input for controlling various kinds of devices. BCI is currently largely used in the healthcare ...  |  read more...
USD 6,500
Market Highlights: France Schizophrenia – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, schizophrenia drugs market share, schizophrenia drugs sales estimates, schizophrenia drugs sales forecast, and schizophrenia late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023
3/31/2014 | published by: GlobalData
... during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes ...  |  read more...
USD 10,995
MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts
4/30/2014 | published by: GlobalData
... neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices. The neurovascular interventions ...  |  read more...
USD 4,450
MediPoint: Neurovascular Interventions - APAC Analysis and Market Forecasts
4/30/2014 | published by: GlobalData
... interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices. The APAC neurovascular interventions ...  |  read more...
USD 4,450
Market Highlights: US Schizophrenia – 2014
5/1/2014 | published by: Fore Pharma
... the US schizophrenia market size estimates for 2013, market share forecast for six years to 2019, schizophrenia drugs market share, schizophrenia drugs sales estimates, schizophrenia drugs sales forecast, and schizophrenia late stage pipeline products.This research ...  |  read more...
USD 990
OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018
3/12/2014 | published by: GlobalData
... is off-label use of a multitude of other drugs which target different core and non-core symptoms of ASD. Since this disorder can first become apparent in very young children there is a need for medications ...  |  read more...
USD 7,995
MediPoint: Neurovascular Interventions - EU Analysis and Market Forecasts
4/30/2014 | published by: GlobalData
... interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices. The neurovascular interventions market ...  |  read more...
USD 4,450
Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014
6/20/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Mild Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Brain Metastasis Global Clinical Trials Review, H1, 2014
2/26/2014 | published by: GlobalData
... information and data relating to the clinical trials on Brain Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
3  4  5  6    8    10  11  12